![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
How McKesson Helps Health Systems Balance Effectiveness and Cost
Working closely with your primary vendor to meet DSCSA requirements
By
Date
June 19, 2023
Read time: 3 minutes
By: McKesson Editorial Team
Health systems can benefit from working closely with their primary vendor to address the upcoming requirements to the Drug Supply Chain Security Act (DSCSA). In fact, partnering with a trusted company like McKesson not only helps health systems meet key compliance requirements, it can also help balance effectiveness and cost.
In 2013, Congress enacted the Drug Supply Chain Security Act to enhance patient safety by preventing counterfeit, adulterated, or stolen drugs from entering the pharmaceutical supply chain. Since then, DSCSA has implemented several milestones, including product tracing requirements and serialization requirements.
November 27, 2023 marks the deadline for manufacturers, repackagers, distributors, and dispensers to comply with enhanced drug distribution security requirements. The requirements include enhanced verification of product identifiers; the use of an electronic. Interoperable system exchange of serial DSCSA Transaction Information; quarantine and investigation of suspect products; and verification of authorized trading partners.
As your trusted partner, McKesson is ready to address the needs of your health system to help you stay DSCSA compliant, while also balancing effectiveness and cost. Furthermore, Scott Mooney, VP Distribution Operations at McKesson, is nationally recognized for his expertise on DSCSA actions and requirements.
How McKesson Can Help Balance Effectiveness and Cost
Streamlined Supply Chain: A primary vendor like McKesson acts as a single point of contact in a health system's pharmaceutical supply chain, precluding the need to order from multiple manufacturers and distributors. This reduces the administrative burden of managing multiple relationships and orders. It also helps to ensure compliance with DSCSA requirements, such as product tracing and verification, by centralizing data and documentation.
Enhanced Visibility and Traceability: DSCSA requires pharmaceutical products to be traced and verified throughout the supply chain to ensure their authenticity. McKesson can provide health systems with enhanced visibility and traceability by utilizing advanced technologies to accurately capture and record product information at each point in the supply chain.
Cost Savings: By consolidating orders and leveraging economies of scale, McKesson can negotiate with manufacturers and suppliers, resulting in potential cost savings for health systems. This can help health systems optimize their pharmaceutical procurement processes, reduce costs, and improve their overall financial performance while ensuring compliance with DSCSA requirements.
Operational Efficiency: McKesson can also help improve operational efficiency. With a single point of contact, health systems can streamline their procurement processes, reduce paperwork, and minimize the time and effort required to manage multiple vendor relationships.
Expertise and Support: McKesson is a trusted voice in the industry with extensive expertise in pharmaceutical supply chain management and DSCSA compliance. We can provide health systems with valuable guidance, support, and education on best practices for DSCSA compliance, including training on product tracing, verification, and other regulatory requirements. This helps health systems stay compliant with DSCSA while minimizing the risk of non-compliance penalties or other legal and financial risks.
By working closely with a primary vendor like McKesson for DSCSA, your health system can balance effectiveness and cost by streamlining the supply chain, enhancing visibility and traceability, achieving cost savings, improving operational efficiency, and leveraging the expertise and support of a specialized partner. This can allow your health system to optimize your pharmaceutical procurement processes, ensure compliance with DSCSA requirements, and focus on delivering high-quality patient care.
Is your health system DSCSA ready? Read the key compliance requirements or contact us to learn how McKesson can help you achieve more.
Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Related Stories
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
The most downloaded content by health system pharmacy leaders in July 2025.
A recent podcast includes first-hand insights on opportunities for collaboration in strengthening the supply chain to achieve more.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.
The top three Prescribed Perspectives articles downloaded by health systems in June.